BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31913510)

  • 1. Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): Comparison with a structured clinical diagnostic interview.
    Recklitis CJ; Blackmon JE; Chang G
    Cancer; 2020 Apr; 126(7):1568-1575. PubMed ID: 31913510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating the Patient-Reported Outcomes Measurement Information System Short Form v1.0-Anxiety 8a in a sample of young adult cancer survivors: Comparison with a structured clinical diagnostic interview.
    Recklitis CJ; Blackmon JE; Chevalier LL; Chang G
    Cancer; 2021 Oct; 127(19):3691-3697. PubMed ID: 34196978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening young adult cancer survivors for distress with the Distress Thermometer: Comparisons with a structured clinical diagnostic interview.
    Recklitis CJ; Blackmon JE; Chang G
    Cancer; 2016 Jan; 122(2):296-303. PubMed ID: 26457669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview.
    Recklitis CJ; Blackmon JE; Chang G
    Psychol Assess; 2017 Oct; 29(10):1189-1200. PubMed ID: 28080106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening young adult cancer survivors for depression and anxiety with the Primary Care Evaluation of Mental Disorders (PRIME-MD): Comparisons with a structured clinical diagnostic interview.
    Chevalier LL; Blackmon JE; Roman A; Chang G; Recklitis CJ
    Psychooncology; 2023 Jul; 32(7):1122-1129. PubMed ID: 37221443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Insomnia Severity Index (ISI) for identifying insomnia in young adult cancer survivors: comparison with a structured clinical diagnostic interview of the DSM-5 (SCID-5).
    Michaud AL; Zhou ES; Chang G; Recklitis CJ
    Sleep Med; 2021 May; 81():80-85. PubMed ID: 33640841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey.
    Walsh TL; Homa K; Hanscom B; Lurie J; Sepulveda MG; Abdu W
    Spine J; 2006; 6(3):316-20. PubMed ID: 16651227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Three-Item Insomnia Severity Index Short Form in Young Adult Cancer Survivors: Comparison with a Structured Diagnostic Interview.
    Chevalier LL; Michaud AL; Zhou ES; Chang G; Recklitis CJ
    J Adolesc Young Adult Oncol; 2022 Dec; 11(6):596-599. PubMed ID: 35085459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-tier process for screening depression and anxiety among children and adolescents with cancer.
    Yardeni M; Abebe Campino G; Bursztyn S; Shamir A; Mekori-Domachevsky E; Toren A; Gothelf D
    Psychooncology; 2020 Dec; 29(12):2019-2027. PubMed ID: 32691478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic operating characteristics of PROMIS scales in screening for depression.
    Kroenke K; Stump TE; Kean J; Krebs EE; Damush TM; Bair MJ; Monahan PO
    J Psychosom Res; 2021 Aug; 147():110532. PubMed ID: 34052655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
    Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
    Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort.
    Allen J; Alpass FM; Stephens CV
    Qual Life Res; 2018 Aug; 27(8):2207-2215. PubMed ID: 29725968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients.
    Clover K; Lambert SD; Oldmeadow C; Britton B; King MT; Mitchell AJ; Carter G
    Qual Life Res; 2018 May; 27(5):1357-1367. PubMed ID: 29423755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis.
    Levis B; Sun Y; He C; Wu Y; Krishnan A; Bhandari PM; Neupane D; Imran M; Brehaut E; Negeri Z; Fischer FH; Benedetti A; Thombs BD; ; Che L; Levis A; Riehm K; Saadat N; Azar M; Rice D; Boruff J; Kloda L; Cuijpers P; Gilbody S; Ioannidis J; McMillan D; Patten S; Shrier I; Ziegelstein R; Moore A; Akena D; Amtmann D; Arroll B; Ayalon L; Baradaran H; Beraldi A; Bernstein C; Bhana A; Bombardier C; Buji RI; Butterworth P; Carter G; Chagas M; Chan J; Chan LF; Chibanda D; Cholera R; Clover K; Conway A; Conwell Y; Daray F; de Man-van Ginkel J; Delgadillo J; Diez-Quevedo C; Fann J; Field S; Fisher J; Fung D; Garman E; Gelaye B; Gholizadeh L; Gibson L; Goodyear-Smith F; Green E; Greeno C; Hall B; Hampel P; Hantsoo L; Haroz E; Harter M; Hegerl U; Hides L; Hobfoll S; Honikman S; Hudson M; Hyphantis T; Inagaki M; Ismail K; Jeon HJ; Jetté N; Khamseh M; Kiely K; Kohler S; Kohrt B; Kwan Y; Lamers F; Asunción Lara M; Levin-Aspenson H; Lino V; Liu SI; Lotrakul M; Loureiro S; Löwe B; Luitel N; Lund C; Marrie RA; Marsh L; Marx B; McGuire A; Mohd Sidik S; Munhoz T; Muramatsu K; Nakku J; Navarrete L; Osório F; Patel V; Pence B; Persoons P; Petersen I; Picardi A; Pugh S; Quinn T; Rancans E; Rathod S; Reuter K; Roch S; Rooney A; Rowe H; Santos I; Schram M; Shaaban J; Shinn E; Sidebottom A; Simning A; Spangenberg L; Stafford L; Sung S; Suzuki K; Swartz R; Tan PLL; Taylor-Rowan M; Tran T; Turner A; van der Feltz-Cornelis C; van Heyningen T; van Weert H; Wagner L; Li Wang J; White J; Winkley K; Wynter K; Yamada M; Zhi Zeng Q; Zhang Y
    JAMA; 2020 Jun; 323(22):2290-2300. PubMed ID: 32515813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of PROMIS Depression and Anxiety Measures Compared with DSM-5 Diagnostic Criteria in Musculoskeletal Patients.
    Cheng AL; Downs DL; Brady BK; Hong BA; Park P; Prather H; Hunt DM
    JB JS Open Access; 2023; 8(1):. PubMed ID: 36698984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Web-based screening instrument for depression and anxiety disorders in primary care.
    Farvolden P; McBride C; Bagby RM; Ravitz P
    J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.
    Marrie RA; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott JJ; Bernstein CN
    Mult Scler Relat Disord; 2018 Feb; 20():9-15. PubMed ID: 29274564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal Clinically Important Difference and Substantial Clinical Benefit Using PROMIS CAT in Cervical Spine Surgery.
    Steinhaus ME; Iyer S; Lovecchio F; Khechen B; Stein D; Ross T; Yang J; Singh K; Albert TJ; Lebl D; Huang R; Sandhu H; Rawlins B; Schwab F; Lafage V; Kim HJ
    Clin Spine Surg; 2019 Nov; 32(9):392-397. PubMed ID: 31569175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods.
    Vilagut G; Forero CG; Pinto-Meza A; Haro JM; de Graaf R; Bruffaerts R; Kovess V; de Girolamo G; Matschinger H; Ferrer M; Alonso J;
    Value Health; 2013 Jun; 16(4):564-73. PubMed ID: 23796290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.